F-1: Phaos Technology Holdings Eyes US Expansion with $15.5M IPO

Phaos Technology Holdings, a Cayman Islands-based microscopy solutions provider, is set to launch an initial public offering on the NYSE American, aiming to raise approximately US$15.5 million.

Summary

• Phaos Technology Holdings, a Cayman Islands-based holding company, is planning an initial public offering (IPO) of 2,700,000 Class A Ordinary Shares.
• The anticipated IPO price is between US$[4.00] and US$[5.00] per share, with an assumed midpoint of US$[4.50].
• The company has applied to list its Class A Ordinary Shares on the NYSE American under the symbol [POAS].
• Phaos Technology Holdings operates through its Singapore-based subsidiary, focusing on advanced microscopy solutions.
• The company's revenue grew by 189.3% from S$650,797 in 2023 to S$1,882,803 in 2024.
• Net loss increased by 41.5% from S$1,667,823 in 2023 to S$2,359,844 (US$1,730,712) in 2024.
• The company intends to use the net proceeds from the offering for marketing (5%), product development (15%), supply chain expansion (20%), and general working capital (60%).
• The underwriter, Network 1 Financial Securities Inc., has an option to purchase up to [405,000] additional Class A Ordinary Shares within 45 days to cover over-allotments.
• Post-IPO, Beh Hook Seng will control approximately [50.03]% of the total voting power through his ownership of TongHuai SG Enterprise Pte. Ltd and TongHuai SG2 Enterprise Pte. Ltd.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While there's strong revenue growth, the increasing net losses and accumulated deficit raise concerns. The company's future plans and competitive strengths offer some optimism, but the risks associated with the business and the IPO need careful consideration.

Positives

• The company experienced significant revenue growth of 189.3% from 2023 to 2024.
• The company has a diverse customer base across various industries.
• The company offers integrated hardware and software solutions, providing a competitive edge.
• The company has a strong sales network in the optical application market in Asia.
• The company is expanding its business and operations through joint ventures and strategic alliances.
• The company is widening its product range and solutions to meet future client needs.

Negatives

• The company's net loss increased by 41.5% from 2023 to 2024.
• The company has an accumulated deficit of S$7,030,066 (US$5,155,849) as of April 30, 2024.
• The company is an emerging growth company and a foreign private issuer, which may result in reduced reporting requirements.
• The company will be a controlled company, which may limit investors' ability to influence corporate matters.
• The company relies heavily on its top 5 customers, who accounted for 91% of total revenue in 2024.

Risks

• The company is susceptible to fluctuations in the prices and quantity of materials and components used in the manufacturing of its microscopy equipment.
• The company's continued success is dependent on its key management personnel.
• The company's reputation and profitability may be adversely affected if there are major failures or malfunction in its microscopy equipment.
• The company is affected by regional and worldwide political, regulatory, social and economic conditions.
• The company is exposed to the credit risks of its customers.
• The company's business is subject to supply chain interruptions.
• The company may be affected by a re-occurrence or a prolonged global pandemic outbreak of COVID-19.
• The company may not be able to successfully implement its business strategies and future plans.
• An active trading market for the company's Class A Ordinary Shares may not be established.
• The trading price of the company's Class A Ordinary Shares may be volatile.
• The company may be classified as a passive foreign investment company (PFIC).
• The company's Controlling Shareholder has substantial influence over the Company.

Future Outlook

The company plans to expand into new countries, broaden its marketing approach, strengthen its distribution network, and widen its product range and solutions.

Management Comments

• Mr. Andrew Yeo, Executive Director and Chief Executive Officer, has played a pivotal role in driving the expansion of our Group.
• Mr. Tay Beng Boon, Chief Operation Officer, is charged with enhancing operational effectiveness, leading product research and development, and overseeing services within the company.

Industry Context

The microscopy equipment industry is growing and increasingly competitive, with competitors having well-recognized brands and greater financial resources.

Comparison to Industry Standards

• The company competes with Keyence Corp. (TYO:6861), Nikon Corp. (TYO:7731), Olympus Corp. (TYO: 7733), and Hirox Co. Ltd.
• Keyence's IM Series and VHX Series are similar to the company's products.
• Nikon's LV Series and ECLIPSE Series are similar to the company's products.
• Olympus's MX Series, DSX Series and CX Series are similar to the company's products.
• Hirox's HRX Series is similar to the company's products.

Related Party Transactions

• The Company received advances from major shareholder, Tonghuai SG Enterprise Pte. Ltd. for business working purposes.
• The payable balance due to Tonghuai SG Enterprise Pte. Ltd. was S$2,962,000 and S$732,753 (US$537,401) as of April 30, 2023 and 2024.
• Such balance is interest free, unsecured, and due on demand without an agreement.

Stakeholder Impact

• Shareholders will experience immediate and substantial dilution in the pro forma as adjusted net tangible book value of their Class A Ordinary Shares.
• The company's Controlling Shareholder could have considerable influence or control over the outcome of any corporate transactions or other matters submitted to the shareholders for approval.
• The company's employees are subject to health and safety regulations and penalties.
• The company's customers may be affected by major failures or malfunction in its microscopy equipment.
• The company's suppliers are subject to the laws, regulations, and government policies in each jurisdiction where the company operates or plans to expand.

Next Steps

• The company plans to strategically expand into new countries to enhance existing customer support and broaden its global presence.
• The company plans to broaden its marketing approach, shifting to digital marketing in Southeast Asia, China, Taiwan, and Korea.
• The company continues to expand its distribution network in order to capture a higher market penetration rate in existing markets and to continue to develop into new markets.
• The company continues to expand on future client needs based on four directions: specific product range(s) for specific ground applications, total solution for customers pain points, building new technologies into existing products to fulfill the needs of the future market, and providing calibration and certification services.

Key Dates

Keywords

microscopy, IPO, Phaos Technology Holdings, initial public offering, NYSE American, Class A Ordinary Shares, super-resolution microscopy, optical equipment, Singapore, technology